These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 18942003)
21. Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe. Peng ZW; Liang HH; Chen MS; Zhang YJ; Li JQ; Zhang YQ; Lau WY Eur J Surg Oncol; 2008 Feb; 34(2):166-72. PubMed ID: 17851020 [TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation for the treatment of liver tumors in the caudate lobe. Seror O; Haddar D; N'Kontchou G; Ajavon Y; Trinchet JC; Beaugrand M; Sellier N J Vasc Interv Radiol; 2005 Jul; 16(7):981-90. PubMed ID: 16002506 [TBL] [Abstract][Full Text] [Related]
23. Microwave coagulation therapy for unresectable hepatocellular carcinoma. Aramaki M; Kawano K; Ohno T; Sasaki A; Tahara K; Kai S; Iwashita Y; Kitano S Hepatogastroenterology; 2004; 51(60):1784-7. PubMed ID: 15532826 [TBL] [Abstract][Full Text] [Related]
24. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605 [TBL] [Abstract][Full Text] [Related]
25. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050 [TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study. Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S Hepatogastroenterology; 2007 Jun; 54(76):985-9. PubMed ID: 17629022 [TBL] [Abstract][Full Text] [Related]
27. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies. Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599 [TBL] [Abstract][Full Text] [Related]
28. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience. Liang P; Wang Y; Zhang D; Yu X; Gao Y; Ni X J Urol; 2008 Sep; 180(3):844-8; discussion 848. PubMed ID: 18635230 [TBL] [Abstract][Full Text] [Related]
29. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Lu MD; Yin XY; Xie XY; Xu HX; Xu ZF; Liu GJ; Kuang M; Zheng YL Br J Surg; 2005 Nov; 92(11):1393-8. PubMed ID: 16044409 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies. Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567 [TBL] [Abstract][Full Text] [Related]
31. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427 [TBL] [Abstract][Full Text] [Related]
32. Needle tract seeding after radiofrequency ablation of hepatic tumors. Jaskolka JD; Asch MR; Kachura JR; Ho CS; Ossip M; Wong F; Sherman M; Grant DR; Greig PD; Gallinger S J Vasc Interv Radiol; 2005 Apr; 16(4):485-91. PubMed ID: 15802448 [TBL] [Abstract][Full Text] [Related]
33. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338 [TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe. Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414 [TBL] [Abstract][Full Text] [Related]
35. [Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: analysis of major complications in 693 patients]. Wang XH; Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Liu FY Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):945-9. PubMed ID: 23336384 [TBL] [Abstract][Full Text] [Related]
36. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723 [TBL] [Abstract][Full Text] [Related]
37. Percutaneous and laparoscopic approaches of radiofrequency ablation treatment for liver cancer. Yokoyama T; Egami K; Miyamoto M; Watanabe H; Hasegawa H; Iida S; Suzuki S; Nakamura Y; Okawa K; Hagiwara N; Takashima Y; Yoshioka M; Tajiri T; Onda M J Hepatobiliary Pancreat Surg; 2003; 10(6):425-7. PubMed ID: 14714162 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Izumi N; Asahina Y; Noguchi O; Uchihara M; Kanazawa N; Itakura J; Himeno Y; Miyake S; Sakai T; Enomoto N Cancer; 2001 Mar; 91(5):949-56. PubMed ID: 11251946 [TBL] [Abstract][Full Text] [Related]